Effectiveness and Safety of Off-label Dosing of Non–vitamin K Antagonist Anticoagulant for Atrial Fibrillation in Asian Patients

Non–vitamin K antagonist anticoagulants (NOACs) have been used to prevent thromboembolism in patients with atrial fibrillation (AF) and shown favorable clinical outcomes compared with warfarin. However, off-label use of NOACs is frequent in practice, and its clinical results are inconsistent. Furthe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kwang-No, Choi, Jong-Il, Boo, Ki Yung, Kim, Do Young, Kim, Yun Gi, Oh, Suk-Kyu, Baek, Yong-Soo, Lee, Dae In, Roh, Seung-Young, Shim, Jaemin, Kim, Jin Seok, Kim, Young-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000392/
https://www.ncbi.nlm.nih.gov/pubmed/32019993
http://dx.doi.org/10.1038/s41598-020-58665-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000392/
https://www.ncbi.nlm.nih.gov/pubmed/32019993
http://dx.doi.org/10.1038/s41598-020-58665-5

Ejemplares similares